The strikingly different efficacy of AIs in WT and hHGF KI SCID mice suggests that stroma-derived HGF represents a major source of resistance to anti-angiogenic therapy of metastatic colorectal cancer, at least in the orthotopic models analyzed. This evidence concerns the gene HGF and metastatic colorectal cancer.